Stefano Accorsi holds a graduation in Chemistry at the University of Modena (Italy) and an Executive MBA at the Bologna Business School and has been working in the International Regulatory Affairs for more than twenty years. Today, he leads and develops the Company relationship with Regulatory Authorities world-wide, in collaboration with external industry associations and is responsible for the regulatory intelligence activities globally. Stefano is member of several EFPIA Regulatory Working Groups, of the IFPMA Regulatory Science Committee, the Regulatory Affairs Steering Committee at the US Biotechnology Innovation Organization (BIO) and of the EU Regulatory Intelligence Group (EU RING).

Pharmacist by training, Bertrand started his career as a regulatory professional in the bio-pharma industry more than 20 years ago. He held various positions in national, regional and global RA departments, in several companies such as 3M Pharmaceuticals, Baxter and Janssen. He gathered comprehensive experience in the areas of drug development, clinical trials and pre-approval interactions with Health Authorities as well as a strong knowledge base of the of the EU and global regulatory landscape. Since 2019, Bertrand is leading the Regulatory Policy & Intelligence function at Shionogi Europe. He is representing his company at the EU Trade Association EUCOPE where he is co-leading the Clinical Trial Focus Group.

Kasia is chemist by training and has have been working in the pharmaceutical industry since 2006 in generic and a research-based biopharmaceutical sectors, in various human regulatory affairs roles, predominantly in post-marketing authorisation (from affiliate and HQ perspective), drug development and since 2018 in Regulatory Intelligence and Policy at UCB. Kasia is representing UCB at various Trade Associations (BIA, ABPI, EFPIA ERAO working groups) and is currently Co-Chair of the EU Regulatory Intelligence Networking Group (EU RING).